Y. Tasaki

发表

Polymorphic tandem repeats in dopamine D4 receptor are spread over primate species.

M. Matsumoto, K. Hidaka, S. Tada, 1995, Biochemical and biophysical research communications.

1‐Benzyl‐1,2,3,4‐Tetrahydroisoquinoline as a Parkinsonism‐Inducing Agent: A Novel Endogenous Amine in Mouse Brain and Parkinsonian CSF

S. Ohta, Y. Kotake, M. Hirobe, 1995, Journal of neurochemistry.

β-amyloid deposits in transgenic mice expressing human β-amyloid precursor protein have the same characteristics as those in Alzheimer's disease

Y. Tasaki, S. Kawabata, A. Iwai, 2001, Neuroscience.

Chronic administration of 1-benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous amine in the brain, induces parkinsonism in a primate

S. Ohta, Y. Kotake, M. Hirobe, 1996, Neuroscience Letters.

1‐Methyl‐ 1,2,3,4‐Tetrahydroisoquinoline, Decreasing in 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine‐Treated Mouse, Prevents Parkinsonism‐Like Behavior Abnormalities

S. Ohta, M. Hirobe, Y. Tasaki, 1991, Journal of neurochemistry.

Confirmation of the enantiomers of 1-methyl-1,2,3,4-tetrahydroisoquinoline in the mouse brain and foods applying gas chromatography/mass spectrometry with negative ion chemical ionization.

S. Ohta, M. Hirobe, Y. Tasaki, 1990, Biomedical & environmental mass spectrometry.

Metabolism and brain accumulation of tetrahydroisoquinoline (TIQ) a possible parkinsonism inducing substance, in an animal model of a poor debrisoquine metabolizer.

S. Ohta, M. Hirobe, Y. Tasaki, 1990, Life sciences.

Neuroprotective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline on cultured rat mesencephalic neurons in the presence or absence of various neurotoxins

Katsuhiro Okuda, S. Ohta, Y. Kotake, 2005, Brain Research.

In vitro pharmacological profile of YM‐43611, a novel D2‐like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors

S. Usuda, M. Matsumoto, K. Hidaka, 1996, British journal of pharmacology.

The synthesis and structure-activity relationship of substituted N-phenyl anthranilic acid analogs as amyloid aggregation inhibitors.

Harry LeVine, H. Levine, L. Walker, 2009, Bioorganic & medicinal chemistry letters.

Formation of a Novel and Neurotoxic Tetrahydroisoquinoline Derivative, 1,3-Dimethyltetrahydroisoquinoline (1, 3DiMeTIQ), a Condensation Product of Amphetamines and Acetaldehyde in Vivo

S. Ohta, M. Hirobe, Y. Tasaki, 1990 .

Low Levels of mRNA for Dopamine D4 Receptor in Human Cerebral Cortex and Striatum

M. Matsumoto, K. Hidaka, S. Tada, 1996, Journal of neurochemistry.

Full-length cDNA cloning and distribution of human dopamine D4 receptor.

M. Matsumoto, K. Hidaka, S. Tada, 1995, Brain research. Molecular brain research.

Differential effects of [3H]nemonapride and [3H]spiperone binding on human dopamine D4 receptors

M. Matsumoto, K. Hidaka, S. Tada, 1995, Neuroscience Letters.

A Novel Endogenous Amine, 1-Benzyl-1,2,3,4-Tetrahydroisoquinoline(1BnTIQ) in Parkinsonian CSF, and Its Toxicological Effect

S. Ohta, Y. Kotake, M. Hirobe, 1995 .

A Novel and Neurotoxic Tetrahydroisoquinoline Derivative In Vivo: Formation of 1,3‐Dimethyl‐1,2,3,4‐Tetrahydroisoquinoline, a Condensation Product of Amphetamines, in Brains of Rats Under Chronic Ethanol Treatment

S. Ohta, M. Hirobe, Y. Tasaki, 1990, Journal of neurochemistry.

Importance of 1-Methyltetrahydroisoquinoline (1MeTIQ) in Parkinson’s Disease

S. Ohta, M. Hirobe, Y. Tasaki, 1990 .

beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease.

Y. Tasaki, S. Kawabata, A. Iwai, 2001, Neuroscience.

Biosynthesis of 1-methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ), a possible antiparkinsonism agent.

S. Ohta, M. Hirobe, Y. Tasaki, 1993, Advances in neurology.

The synthesis and structure-activity relationship of substituted N-phenyl anthranilic acid analogs as amyloid aggregation inhibitors.

H. Levine, L. Walker, M. Callahan, 2009, Bioorganic & medicinal chemistry letters.